|
Re: Covid opportunity
|
6
|
Resverlogix Corp.
|
Mar 08, 2021 04:20PM
|
|
Re: Covid and apabetalone
|
4
|
Resverlogix Corp.
|
Oct 21, 2020 03:05AM
|
|
Re: COVID 19 - Standard of Care
|
5
|
Resverlogix Corp.
|
Apr 22, 2021 01:21PM
|
|
Re: COVID 19 & BP
|
8
|
Resverlogix Corp.
|
Jun 27, 2020 01:37PM
|
|
Re: Covid
|
1
|
Resverlogix Corp.
|
Aug 14, 2022 09:20PM
|
|
Re: Covid
|
7
|
Resverlogix Corp.
|
Aug 12, 2022 01:06PM
|
|
Re: Courtesy
|
4
|
Resverlogix Corp.
|
Aug 18, 2017 10:36PM
|
|
Re: Courtesy
|
5
|
Resverlogix Corp.
|
Aug 23, 2017 10:47AM
|
|
Re: Could there be another shoe waiting to drop?
|
6
|
Resverlogix Corp.
|
May 20, 2019 02:31AM
|
|
Re: Could there be another shoe waiting to drop?
|
3
|
Resverlogix Corp.
|
May 20, 2019 02:23PM
|
|
Re: Could BETonMACE Cognition Sub-Study be presented at AAIC this month?
|
5
|
Resverlogix Corp.
|
Jul 03, 2019 02:36PM
|
|
Re: Coronary Artery Calcium Score
|
8
|
Resverlogix Corp.
|
Feb 18, 2019 06:14PM
|
|
Re: Corona- COVID-19
|
7
|
Resverlogix Corp.
|
Mar 05, 2020 01:46PM
|
|
Re: Corona- COVID-19
|
6
|
Resverlogix Corp.
|
Mar 05, 2020 08:16PM
|
|
Re: Corona- COVID-19
|
4
|
Resverlogix Corp.
|
Mar 05, 2020 08:43PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
5
|
Resverlogix Corp.
|
Apr 15, 2021 05:00PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
4
|
Resverlogix Corp.
|
Apr 16, 2021 01:16AM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
4
|
Resverlogix Corp.
|
Apr 14, 2021 05:38PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
7
|
Resverlogix Corp.
|
Apr 14, 2021 10:18PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
9
|
Resverlogix Corp.
|
Apr 12, 2021 03:04PM
|
